Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Diana Ramírez‐Flores"'
Autor:
José Ignacio Cerrillos‐Gutiérrez, Diana Ramírez‐Flores, Alfredo Gutiérrez‐Govea, Jorge Andrade‐Sierra, Miguel Medina‐Pérez, Enrique Rojas‐Campos
Publikováno v:
Clinical Case Reports, Vol 10, Iss 7, Pp n/a-n/a (2022)
Abstract The mycetoma is a granulomatous chronic disease, subcutaneous disease is the common presentation, very few cases are reported affecting central nervous system, but there are not cases in Renal Transplant (RT).
Externí odkaz:
https://doaj.org/article/925b3712e6394788939ea10bfefcae19
Autor:
Diana Ramírez Flores, Jorge Andrade-Sierra, Enrique Rojas-Campos, Luis A. Evangelista-Carrillo, Alejandro Heredia-Pimentel, José Luis Montañez-Fernández, Leonardo Pazarín-Villaseñor, José Ignacio Cerrillos-Gutiérrez
Publikováno v:
Revista Colombiana de Nefrología, Vol 9, Iss 2 (2022)
Contexto: la procalcitonina (PCT) podría ser útil en la evaluación de la función del injerto renal (IR) en el postrasplante inmediato, ya que sus niveles se incrementan posterior a la elevación de citocinas inflamatorias (IL-6, TNF-?) durante ev
Externí odkaz:
https://doaj.org/article/f14faa6acfe7496181c678579dc1c908
Autor:
Alejandra Guillermina Miranda-Díaz, Miguel Medina-Pérez, Luis Alberto Evangelista-Carrillo, Petra Martínez-Martínez, Enrique Rojas-Campos, José Ignacio Cerrillos-Gutiérrez, Diana Ramírez Flores, Basilio Jalomo-Martínez, Alejandro Heredia-Pimentel, Eduardo González-Espinoza, Jorge Andrade-Sierra, Juan José Nieves-Hernández, Benjamín Gómez-Navarro
Publikováno v:
International Journal of Infectious Diseases, Vol 107, Iss, Pp 18-24 (2021)
Background In our population, anti-thymocyte globulin (ATG) of 1 mg/Kg/day for 4 days is used; which permits not using valgancyclovir (VGC) prophylaxis in some renal transplant recipients (RTR) with moderate risk (R+), to reduce costs. This study aim
Autor:
Jorge Andrade-Sierra, Alejandro Heredia-Pimentel, Enrique Rojas-Campos, Diana Ramírez Flores, José I. Cerrillos-Gutierrez, Alejandra G. Miranda-Díaz, Luis A. Evangelista-Carrillo, Petra Martínez-Martínez, Basilio Jalomo-Martínez, Eduardo Gonzalez-Espinoza, Benjamin Gómez-Navarro, Miguel Medina-Pérez, Juan José Nieves-Hernández
Publikováno v:
International Journal of Infectious Diseases, Vol 107, Iss , Pp 18-24 (2021)
Background: In our population, anti-thymocyte globulin (ATG) of 1 mg/Kg/day for 4 days is used; which permits not using valgancyclovir (VGC) prophylaxis in some renal transplant recipients (RTR) with moderate risk (R+), to reduce costs. This study ai
Externí odkaz:
https://doaj.org/article/5c9104f01a55419087a1f0146c07e117